-
Mashup Score: 0
Combination of AI-enabled clinical trial matching, genetic testing, symptom management, psychosocial, and lifestyle support addresses physical and mental health gaps patients experience in seeking and accessing treatments while accelerating access to these critical resources. ASCO Annual Meeting – Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platform, today announced a partnership to significantly expand patient access to psycho
Source: www.morningstar.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0Ontrak Launches Groundbreaking Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery - 6 month(s) ago
Ontrak Launches Groundbreaking Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery Ontrak Inc (NASDAQ: OTRK), a leading AI-powered and technology-enabled healthcare company, today announced the launch of its pioneering Mental Health Digital Twin (MHDT) technology. This innovative advancement in mental health care delivery seamlessly fuses human empathy with data-driven insights to provide personalized, precise, and effective care for individuals struggling with
Source: www.morningstar.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
CHICAGO, May 7, 2024 /PRNewswire/ — The Chicago School announced that its new proposed Illinois College of Osteopathic Medicine (IllinoisCOM) has been granted Candidate Status from the Commission on Osteopathic College Accreditation (COCA) – a significant milestone for the institution. Since its founding in 1979, The Chicago School has provided a practical and solutions-oriented education, preparing culturally competent graduates with the skills to improve the health of individuals, organizations, and
Source: www.morningstar.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
‘We don’t really have capex to speak of,’ Reddit CFO Drew Vollero told MarketWatch on the day of the company’s initial public offering last month One aspect of Reddit Inc.’s closely watched initial public offering that has grabbed attention since its debut last month is the social-media platform’s capital expenditure spending, or lack of it. “We don’t really have capex to speak of, “Reddit CFO Drew Vollero told MarketWatch on the day of the company’s offering. “We carry text, which is a lot cheaper to
Source: www.morningstar.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Ackman says he has a ‘psychological short’ on Herbalife after closing out his actual short position in 2018 Shares of Herbalife Ltd. fell more than 30% on Thursday, leading activist investor Bill Ackman to revive his feud with the nutritional-supplements company. Ackman, who lost a yearslong $1 billion bet against Herbalife (HLF), left a long post on X, formerly Twitter, about Herbalife on Thursday, renewing some of his previous accusations that the company was a “pyramid “scheme and saying it was a good
Source: www.morningstar.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 43
SoundHound’s stock roars after Nvidia reveals position worth about $3.7 million as of the end of last year Investors were getting a peek Wednesday at where fund managers have made their bets, as those managers released the required quarterly reports on their holdings. But Wednesday also brought a look at investments made by some public companies, including chip powerhouse Nvidia Cor p. (NVDA), which joined those money managers in filing a 13-F after the closing bell. That’s why Wall Street seemed to be
Source: www.morningstar.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 52Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer - 1 year(s) ago
Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer − FRUZAQLA Plus Best Supportive Care Demonstrated Significant Improvements in Overall Survival, with Corresponding Improvements in Progression Free Survival, Versus Placebo Plus Best Supportive Care in Two Phase 3 Clinical Trials Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy for
Source: www.morningstar.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 48Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer - 1 year(s) ago
Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer − FRUZAQLA Plus Best Supportive Care Demonstrated Significant Improvements in Overall Survival, with Corresponding Improvements in Progression Free Survival, Versus Placebo Plus Best Supportive Care in Two Phase 3 Clinical Trials Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy for
Source: www.morningstar.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Nexion Health Partners with Voyce to Facilitate Clearer Communication Between Staff and Senior Residents - 3 year(s) ago
Nexion Health Partners with Voyce to Facilitate Clearer Communication Between Staff and Senior Residents Nexion Health, Inc., a leading skilled nursing operator serving the Southern region of the United States, has partnered with Voyce, a technology company committed to helping people face language barriers, to improve conversations between healthcare workers and residents. With Voyce’s…
Source: www.morningstar.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Babylon Launches AI in Rwanda in Next Step Towards Digitising Healthcare in Rwanda Babylon Holdings Limited (NYSE: BBLN) (“Babylon”) — a world leading company reengineering how people engage with their health at every step of the care continuum — has launched its AI-powered triage tool in Rwanda to further digitise the Rwandan healthcare system. Babylon, known locally as Babyl, has been…
Source: www.morningstar.comCategories: Healthcare Professionals, Latest HeadlinesTweet
Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe https://t.co/eAwhPJfk5d